Trophogen, Inc. is a biotechnology company founded in 2001 with
series A funding from Toucan Capital, focusing on the development
of high affinity glycoprotein hormone and related growth factor analogs
for human and animal infertility as well as targeted therapy and imaging
of thyroid, ovarian, breast, prostate and testicular cancers.
Research
portfolio
AND
|
Governor's Citation
AWARD CEREMONY
|
(click on picture to enlarge and read
article about citation here)
|
Partnering
Opportunities. Investors.
